Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Liraglutide (Saxenda) Saxenda received FDA approval on December 23, 2014 as the first GLP 1 receptor agonist specifically indicated for chronic weight management
Adverse effects LC is generally well-tolerated
With Eli Lilly's similar drug tirzepatide already approved for weight loss, Novo faces pressure to prove CagriSema can deliver results that justify its high expectations
Every element of the user experience - from intake to injection - is grounded in transparency and professionalism
G., Menichetti, A., Cogliatti, A., Nicoli, P., and Ruvolo, C
US$ 22.55
US$ 28.38
US$ 26.34
US$ 26.26
US$ 27.10
US$ 24.50
US$ 24.13
US$ 23.01
US$ 28.20
US$ 21.46
US$ 20.32
